Navigation Links
The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
Date:11/4/2008

//www.femalehealth.com" target="_new">http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical fact are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this release may be identified by the use of forward-looking words or phrases such as "anticipate," "believe," "could," "expect," "intend," "may," "planned," "potential," "should," "will," "would" or the negative of those terms or other words of similar meaning. These statements are based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, and are made as of the date of this release. The Company assumes no obligation to update any forward-looking statements contained in this release as a result of new information or future events, developments or circumstances. Such forward-looking statements are inherently subject to known and unknown risks and uncertainties. The Company's actual results and future developments could differ materially from the results or developments expressed in, or implied by, these forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to, the following: product demand and market acceptance; competition in the Company's markets and the risk of new competitors and new competitive product introductions; the Company's reliance on its international partners in the consumer sector and on the level of spending on the female condom by country governments, glob
'/>"/>

SOURCE The Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
2. The Female Health Company Reports Record Profit for Both Fourth Quarter and Fiscal Year 2007
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
10. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... licensing agreement under which Proteacel has acquired the exclusive rights to the PORE™ technology for delivery of genes into cells.   , ... , , ... ... ...
(Date:3/18/2010)... ... Structural Genomics Knowledgebase bionformatics resource , ... (PRWEB) -- The Structural Genomics Knowledgebase (SGKB), a ... OpenHelixTM to provide free comprehensive training and outreach programs for its online ...
(Date:3/17/2010)... thicknow appears to be a promising base material for ... Institute of Standards and Technology (NIST) and the University ... could potentially store hydrogen safely for use in fuel ... of a celebrity material in recent years due to ...
(Date:3/17/2010)... A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC ... ... , , ... ...
Breaking Biology Technology:Moffitt Cancer Center Signs Licensing Agreement with Proteacel, LLC 2Moffitt Cancer Center Signs Licensing Agreement with Proteacel, LLC 3Moffitt Cancer Center Signs Licensing Agreement with Proteacel, LLC 4Moffitt Cancer Center Signs Licensing Agreement with Proteacel, LLC 5The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 2The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 3The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB) 4Layered graphene sheets could solve hydrogen storage issues 2Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research 2Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research 3Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research 4
... - Strong 10.3% Growth in First-Quarter Revenue ... in ophthalmic optics, today,announced consolidated revenue of EUR840.4 million for ... increase on the first quarter,of 2008. Excluding the currency effect, ... Despite contracting demand early in the year, revenue was ...
... BioSciences, Inc. (Nasdaq: SGMO ) today announced ... financial results on Wednesday, April 29, 2009, after the ... a conference call at 5:00 p.m. ET, which will ... During the conference call, the company will review the ...
... to Be Held at 9:00 A.M. - EXTON, Pa., ... first quarter financial results for 2009 are expected to be ... the U.S. financial markets.The company will host a conference call ... the same day. During the conference call, ViroPharma management ...
Other Biology Technology:Essilor : 2009 First Quarter Report 2Essilor : 2009 First Quarter Report 3Essilor : 2009 First Quarter Report 4Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast 2Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast 3ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009 2
(Date:3/18/2010)... WHO:,Leaders of SNM , , Michael M. Graham, ... past president, SNM; chair, SNM Medical Isotope Task Force, ... Commission on Radiopharmaceuticals; member, SNM Medical Isotope Task Force, ... that will occur over a two-week period when cancer, ...
(Date:3/18/2010)... effort to mirror the ability of biological tissues to ... the McGowan Institute for Regenerative Medicine have synthesized a ... and chemical toxins. They described the findings recently in ... to create materials that can do many things, just ...
(Date:3/18/2010)... EUREKA project E! 3424 RECAN has developed a range ... the proteins produced in the blood which counteract ... first producing a number of recombinant proteins which are ... themselves have direct uses in immunisation and experimental studies. ...
Breaking Biology News(10 mins):Multifunctional polymer neutralizes both biological and chemical weapons 2Manufacturing antibodies 2Manufacturing antibodies 3ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego CA 59117 1ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego CA 59117 2Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 1Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 2Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 3Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 4Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 1Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 2
... growth hormone auxin is controlled by circadian rhythms within ... explains how plants can time their growth to take ... suggests that many other processes may be influenced by ... from the ground and toward light and water. Charles ...
... ON. August 13, 2007 Scientists have found ... and the protein complexes central to the stability ... contributes to cancer development. , The research, ... sheds new light on the pathology of three ...
... Here is the latest American Chemical Society (ACS) News Service ... Chemical & Engineering News. ,Please credit the individual journal or ... , ,ACS NEWS SERVICE Aug. 8, 2007,Weekly ... #5, which is embargoed for 9 A. M., Eastern Time, ...
Other Biology News:Protein 'chatter' linked to cancer activation 2American Chemical Society's Weekly PressPac -- Aug. 8, 2007 2American Chemical Society's Weekly PressPac -- Aug. 8, 2007 3American Chemical Society's Weekly PressPac -- Aug. 8, 2007 4American Chemical Society's Weekly PressPac -- Aug. 8, 2007 5American Chemical Society's Weekly PressPac -- Aug. 8, 2007 6American Chemical Society's Weekly PressPac -- Aug. 8, 2007 7American Chemical Society's Weekly PressPac -- Aug. 8, 2007 8American Chemical Society's Weekly PressPac -- Aug. 8, 2007 9
... An entire pressurized perfusion system for ... physiology, biophysics, electrochemistry, or general liquid-handling ... little as 100 microliters of precious ... solutions in milliseconds from a single ...
Anti-Digoxigenin-AP, Fab fragments; from sheep...
...
... Partially purified chicken intestinal cytoplasmic ... D receptor (VDR) from human, rat, ... tissues. This antibody does not ... MA1-710 detects both the occupied ...
Biology Products: